This content supports the SDG Goal 3: Good health and well-being by providing information on Hepatitis B and Hepatitis D Viruses.

This content supports the SDG Goal 3: Good health and well-being by discussing the pathogens, epidemiology, clniical manifestations, laboratory findings, treatment and prevention of Hepatitis A.

This chapter advances Goals 16, 10, and 3 by assessing the livelihoods of the Rohingya refugees in Bangladesh with particular reference to the 2020 pandemic and discussing the growing tension between the refugees and the local Bangladeshis.

This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by providing an understanding of understand the inequalities between countries and shifting modality in risk governance. The case studies of COVID-19 pandemic impacts, governance, and consequences have been analyzed from various perspectives at the local, national, and regional levels.

This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by providing an overview of current knowledge of racial/ethnic inequities in health with a focus on the United States and the potential contribution of psychosocial stressors to account for them.

This chapter advances the UN SDG Goal 3: Good Health by providing an overview of research on the use of image data of the built environment to analyze impacts on human health and explaining the challenges that need to be addressed to realize a new data-driven era of urban analysis and planning.

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by discussing the physical deficits, which are accompanied in predictable frequencies by Intellectual Disability and epilepsy, that result from brain injury sustained in utero, during birth, and infancy.

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the clinical aspects, epidemiology, and molecular virology of the major hepatitis viruses.

This chapter aligns with the SDG goal 3 of good health and wellbeing by examining current efforts to treat patients who do not adequately respond to standard immunosuppressive treatments as well as to find novel noninvasive biomarkers that can reliably substitute liver histology in assessing liver fibrosis and in predicting hard long-term outcomes.

This chapter aligns with the SDG goal 3 of good health and wellbeing by showing the evolution of chronic viral hepatitis from fibrosis, to cirrhosis, and to hepatocellular carcinoma.